Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 11809039

Preparing for bioterrorism: category A agents.

D J Persell·P Arangie·C Young·E N Stokes·W C Payne·P Skorga·D Gilbert-Palmer
View original source ↗Export metadata ↓

Abstract

September 11, 2001, brought the possibility of biologic acts of terrorism against the United States into the national consciousness. As the American people brace themselves for this new threat to the national well-being, clinicians must understand how to prevent, recognize, and treat the biologic agents that could be used in terrorist attacks. This article discusses the most likely biologic agents, including diagnostic laboratory procedures, treatment options, psychological effects, special populations, and reporting requirements.

Explore related subjects

AnthraxAnti-Bacterial AgentsAnti-Infective AgentsBioterrorismBotulismCiprofloxacinHumansPlaguePreventive Health ServicesSmallpoxSmallpox VaccineStreptomycinTularemiaJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

D J Persell, P Arangie, C Young, E N Stokes, W C Payne, P Skorga, D Gilbert-Palmer. 2001. Preparing for bioterrorism: category A agents.. https://doi.org/10.1097/00006205-200112000-00003

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2026

Epidemiological and phylogenetic analysis of anthrax in Kazakhstan in 2024.

BACKGROUND: Anthrax remains an important zoonotic disease in Kazakhstan due to the persistence of environmental reservoirs and long-standing endemic foci. Despite ongoing surveillance, the epidemiological characteristics and genetic diversity of circulating Bacillus anthracis strains in the country remain incompletely understood. METHODS: A retrospective epidemiological and phylogenetic investigation of anthrax outbreaks reported in Kazakhstan during 2024 was conducted. Epidemiological data were collected for all laboratory-confirmed human cases and associated outbreak foci. Confirmation of infection was performed by PCR, and B. anthracis isolates were obtained from clinical, environmental and animal-associated samples. Whole-genome sequencing and core-genome single nucleotide polymorphism (cgSNP) analysis were used to characterize the genetic relationships among isolates and to determine their phylogenetic placement. RESULTS: Nine anthrax outbreaks were identified across four regions of Kazakhstan (Almaty, Zhambyl, Atyrau, and West Kazakhstan), resulting in 20 confirmed human cases. All patients were male, with the highest proportion occurring among individuals aged 36-55 years (45%). The mean patient age was 43.9 years (range: 16-64 years). Most infections were associated with slaughtering infected livestock (65%), followed by handling contaminated meat (15%). PCR confirmed infection in all 20 human cases. Culture yielded 17 human-derived B. anthracis isolates from 14 patients and 17 environmental/animal-derived isolates, resulting in 34 isolates in total. Of these, 22 representative isolates underwent whole-genome sequencing. Phylogenetic analysis revealed the circulation of two major lineages. Isolates from Atyrau and West Kazakhstan clustered within the Trans-Eurasian (TEA/STI) lineage. Atyrau isolates formed a tight cluster differing by only 21-32 cgSNPs, consistent with a shared epidemiolocal source, whereas the West Kazakhstan isolate was highly divergent. Zhambyl and Almaty region belonged to the A.Br.Ames lineage but diverged into two distinct sublineages. Zhambyl region isolates demonstrated minimal divergence from the global reference genome Ames Ancestor, differing by only 16-31 SNPs. Almaty region isolates formed an endemic subclone, separated from the reference group by approximately 114 SNPs. Comparison with the Ames Ancestor and Sterne reference strains demonstrated substantial genetic divergence. CONCLUSION: Anthrax outbreaks in Kazakhstan during 2024 were primarily associated with livestock exposure and occurred within established endemic regions. Whole-genome sequencing revealed the coexistence of distinct TEA and Ames lineages, including evidence of persistent local transmission and long-term evolutionary stability of endemic B. anthracis populations. These findings enhance understanding of anthrax epidemiology in Central Asia and support the integration of genomic surveillance into national outbreak investigation programs.

Anthrax↗
PubMed2026

Epidemiological Characteristics of Anthrax and Bacillus anthracis Strains - China, 2020-2024.

INTRODUCTION: The incidence of anthrax in China has declined since 1990 but has resurged in recent years. The purpose of this study was to describe the epidemiology of anthrax and Bacillus anthracis (B. anthracis) in China from 2020 to 2024 to inform control strategies. METHODS: A descriptive analysis was performed of case characteristics. B. anthracis strains underwent whole-genome sequencing, and phylogenetic relationships were determined by core-genome single nucleotide polymorphism (cgSNP) and canonical single nucleotide polymorphism (canSNP) analysis. RESULTS: Between 2020 and 2024, 1,870 anthrax cases were reported, with a 0.59% case fatality rate. The majority of cases were cutaneous and the incidence increased from year to year. Cases were distributed across 12 provincial-level administrative divisions (PLADs), with most regions showing an increased incidence between 2021 and 2024. Farmers and herders were the most affected occupational groups, and farmers accounted for an increasing proportion of cases. Cases were primarily concentrated among young and middle-aged men and peaked between July and September. A total of 185 B. anthracis strains were identified in the 12 PLADs and were classified into four sublineages (A.Br.001/002, A.Br.Ames, A.Br.Vollum, and A.Br.005/006). A.Br.001/002 was the most prevalent and widely distributed sublineage. Phylogenetic analysis revealed 14 branches, demonstrating population diversity. Cross-clustering was present among strains from different PLADs. CONCLUSIONS: From 2020 to 2024, anthrax cases generally followed historical patterns but the incidence increased, with broader geographical spread, more diverse clinical types, and interprovincial transmission. These findings highlight the need to strengthen anthrax control efforts, particularly in the central and eastern PLADs.

Anthrax↗
PubMed2006

Strain-specific single-nucleotide polymorphism assays for the Bacillus anthracis Ames strain.

Highly precise diagnostics and forensic assays can be developed through a combination of evolutionary analysis and the exhaustive examination of genomic sequences. In Bacillus anthracis, whole-genome sequencing efforts revealed ca. 3,500 single-nucleotide polymorphisms (SNPs) among eight different strains and evolutionary analysis provides the identification of canonical SNPs. We have previously shown that SNPs are highly evolutionarily stable, and the clonal nature of B. anthracis makes them ideal signatures for subtyping this pathogen. Here we identified SNPs that define the lineage of B. anthracis that contains the Ames strain, the strain used in the 2001 bioterrorist attacks in the United States. Sequencing and real-time PCR were used to validate these SNPs across B. anthracis strains, including (i) 88 globally and genetically diverse isolates; (ii) isolates that were shown to be genetic relatives of the Ames strain by multiple-locus variable number tandem repeat analysis (MLVA); and (iii) several different lab stocks of the Ames strain, including a clinical isolate from the 2001 letter attack. Six SNPs were found to be highly specific for the Ames strain; four on the chromosome, one on the pX01 plasmid, and one on the pX02 plasmid. All six SNPs differentiated the B. anthracis Ames strain from the 88 unique B. anthracis strains, while five of the six separated Ames from its close genetic relatives. The use of these SNPs coupled with real-time PCR allows specific and sensitive (<100 fg of template DNA) identification of the Ames strain. This evolutionary and genomics-based approach provides an effective means for the discovery of strain-specific SNPs in B. anthracis.

Anthrax↗